The inducibility of tyrosine aminotransferase (EC 2.6.1.5) by corticosteroid hormones in rathuman hybrid clones was studied. The presence of human X chromosome activity in the cells was always associated with the suppression of tyrosine aminotransferase inducibility in all the clones examined. Negative correlation between the human X chromosome and inducibility of the enzyme was clearly established. Corticosteroid receptor was present to the same extent in hybrid cell clones that either contained or lost the human X chromosome. The human repressor for inducible tyrosine aminotransferase has a linkage relationship with glucose-6-phosphate dehydrogenase (EC 1.1.1.49) and hypoxanthine-guaninephosphoribosyltransferase (EC 2.4.2.8) and, therefore, can be assigned to the X chromosome.
Fusion of rat hepatoma cells that produce tyrosine aminotransferase (TAT) (EC 2.6.1.5) with mouse cells results in suppression of the production of the enzyme in the heterokaryocytes (1) . Hybrid cells resulting from such fusion do not produce TAT and are resistant to induction of TAT by corticosteroid hormones (2) . Since loss of rat chromosomes usually occurs during propagation in culture of rat-mouse hybrid cells (2) (3) (4) , genetic analysis of the suppression of production and induction of rat TAT is difficult. Therefore, we turned to rat-human hybrid cells in which loss and segregation of human chromosomes (Croce, C., Kieba, I., and Koprowski, H., manuscript in preparation) and retention of the rat chromosome component make possible a genetic analysis of a regulatory function of the human chromosome(s) in the hybrid cell.
Since inducibility of the development of the Wolffian duct by testosterone seems to be regulated by an X chromosomelinked regulatory gene in mice and perhaps in humans (4) and since other steroid hormones induce TAT, we decided to investigate the possibility that the regulatory gene for inducible TAT is also linked to the X chromosome. We decided to hybridize rat hepatoma cells deficient in hypoxanthineguanine-phosphoribosyltransferase (HGPRT) (EC 2.4.2.8) with normal human fibroblasts that are unable to produce TAT and in which TAT cannot be induced by corticosteroid hormones. If this hybrid is grown in selective hypoxanthineaminopterin-thymidine (HAT) (5) medium, the human Abbreviations: HAT medium, hypoxanthine-aminopterin-thymidine medium; TAT, tyrosine aminotransferase; HGPRT, hypoxanthine-guanine-phosphoribosyltransferase; APRT, adenine phosphoribosyltransferase; G6PD, glucose-6-phosphate dehydrogenase; LDH, lactate dehydrogenase.
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HGPRT structural gene linked to the X chromosome must be expressed in order to permit survival of the hybrid cells in this medium. Conversely, if the hybrid cells, selected in HAT medium, are grown in a high concentration of 8-azaguanine, it is possible to select for hybrid cells that have lost the human X chromosome (6) .
If rat hepatoma-human fibroblast hybrid cells could be produced under the above conditions, then the study of various hybrid cell clones for production of TAT, inducibility of TAT by dexamethasone (7) , and the presence of receptors for dexamethasone (8) (2) . Both these cell lines were obtained from Dr. M. Siniscalco. Mouse cells (Cl-iD) are derived from L cells (9) and are resistant to 30,g/ml of BrdU. The human diploid cell strain (WI-38) is derived from a female embryo (10 (13, 14) . HGPRT activity was determined by the technique of Bakay and Nyhan (15); the nucleotide product was precipated with lanthanum chloride. The gels were incubated in solution containing [8-14C] hypoxanthine and [8-14C] adenine substrate in order to simultaneously detect HGPRT and APRT (15) .
For TAT analysis the monolayers of parental and hybrid cells were kept in serum-free medium with or without 20 .M dexamethasone for 24 hr. The cells were collected after centrifugation at 800 X g for 10 min at 40, washed, and resuspended in extraction medium (0.15 M KCl, 1 mM EDTA, 0.1 mM dithiothreitol, 1 mM 2-oxoglutarate, 0.1 mM pyridoxal phosphate, and 0.1 M potassium phosphate buffer at pH 7.6). This suspension was sonicated by two 10-sec bursts with a chilled probe of a Branson Sonifier at a setting of 5 amp. The sonicated suspension was immediately centrifuged in an RC-2 Sorvall Centrifuge at 20,000 X g for 15 min at 4°. The supernatant solutions were tested for TAT by the method of Canellakis and Cohen (16) and for proteins by the Lowry et al. method (17) . Measurement of Corticosteroid Receptor Activity. To 1.0 ml of the cytosol fraction prepared from 50% homogenates of various washed cell preparations, 35 nM [1,2,4-3H]dexamethasone (New England Nuclear Corp.) was added. The mixture was incubated for 60 min at 00. At the end of the incubation period, each sample was loaded onto a column of Sephadex G-25 (2 X 20 cm) to which was added a drop of dextran blue suspension. The macromolecular bound radioactivity eluted with the dextran blue in 35 ml and the unbound radioactivity was completely eluted by 150 ml of eluent [50 mM Tris HCl, (pH 7.5)]. These experiments were done essentially as described earlier (18) . The activity of the corticosteroid receptor is expressed as the percentage of bound dexamethasone:
(dpm bound [3H]dexamethasone) X 100 = % bound.
(dpm bound) + (dpm unbound) RESULTS Inducibility of TAT in Hybrid Cells. Clones of rat-human hybrid cells were tested for production of TAT and its induction by dexamethasone (Table 1) . TAT activity was not detected in parental human WI-38 cells, and no enzyme induction occurred after exposure of these cells to dexamethasone. On the other hand, the rat hepatoma cells did produce TAT, and after exposure to dexamethasone production of TAT was increased 4-fold (Table 1) .
All rat-human hybrid clones that were maintained in HAT medium showed either no activity or low activity for TAT. After exposure to dexamethasone these values either did not change or were only slightly increased. Conversely, those clones that were originally selected in HAT medium and were then back-selected for growth in 15 sg/ml of 8-azaguanine showed, with the exception of clone 29, higher TAT activity than the parental rat hepatoma cells. After exposure to dexamethasone, production of TAT increased 3-to 6-fold. Clone 29 showed a low amount of TAT and, after exposure to dexamethasone, TAT activity was less than that in all other hybrid clones grown in the presence of 8-azaguanine.
Isozyme Patterns of Rat-Human Hybrid Cells. All hybrid cell clones growing in HAT medium displayed human G6PD and HGPRT activity (Table 1 ). In contrast, except for clone 29, none of the clones grown in 8-azaguanine medium showed Presence of Dexamethasone Receptors in Hybrid Cells. As indicated in Table 3 , the dexamethasone receptor is present to the same extent, as measured by its capability to bind radioactive dexamethasone, in hybrid cell clones that contain the human X chromosome as in those that have lost this chromosome.
TAT Inducibility in Rat-Mouse Hybrid Cells. Giemsa banding staining of rat-mouse hybrid chromosomes in metaphase plates obtained from 15 hybrid clones indicated preferential loss of rat chromosomes and retention of most mouse chromosomes (Croce, C., Kieba, I., and Koprowski, H., manuscript in preparation). The parental mouse-cell cultures did not show any TAT activity, and the enzyme could not be induced (specific activity, 0) by exposure to dexamethasone. Examination of eight different rat-mouse hybrid clones indicated that none of the cultures showed any TAT activity, and TAT could not be induced after exposure of the cultures to dexamethasone (Croce, C., Litwack, G., and Koprowski, H., manuscript in preparation).
DISCUSSION
The results presented in this paper indicate that rat-human hybrid clones selected for the absence of human X chromosome *By dexamethasone (see Table 1 ).
Human Regulatory Gene for Inducible TAT 1271 demonstrate TAT inducibility by dexamethasone. These clones are identified, after selection in 8-azaguanine, by absence of human HGPRT and G6PD and by karyologic analysis.
In clone 29, the human X chromosome was not detected by karyological analysis, although cells of this clone showed human G6PD, but not HGPRT, activity. Chromosomal rearrangement involving part of the X chromosome may have occurred during cultivation of this clone. TAT activity was completely shut off in several rat-human hybrid clones maintained in HAT medium. In other hybrid clones, the base levels of TAT were similar to those of the rat parental cells, but in contrast to the rat cells, TAT was not induced after exposure of the hybrid cultures to dexamethasone. Karyologic analysis and X-linked human isozyme patterns of the rat-human hybrid cells indicated that, with the exception of the active human X chromosome (Fig. 2) , no other human chromosome was always present in the noninducible clones and always absent in the inducible clones. Chromosomal rearrangement, however, may have taken place during propagation of the hybrid cells so that fragments of an autosome, rather than the X chromosome, were involved in suppression of TAT inducibility. This rearrangement is unlikely, since hybrid clones, when transferred to 8-azaguanine medium after growth in HAT medium, showed loss of active X chromosome and inducible TAT activity. Proc. Nat. Acad. Si. USA 70 (1973) The inducibility of TAT in clones in which the human X chromosome is absent is clearly much greater than in the clones in which it is present. If the human X chromosome controls the enzyme inducibility, it must do so by influencing a phenotype other than the level of hormone receptor, since the same receptor activity was found in inducible and noninducible clones.
Others have reported that production and induction of TAT was repressed in hybrid cells produced by fusion of rat hepatoma cells with either normal rat epithelial cells (19) or 3T3 mouse fibroblasts (2) . No assignment for the regulatory gene was made in these studies. Tomkins et al. (20) have postulated the existence of two genes involved in TAT activity, one gene controlling the baseline production of the enzyme and the other its inducibility. With regard to baseline production of TAT, we have observed noninducible clones that showed TAT baseline activity similar to that observed in parental rat cells.
The existence of a human X-linked regulatory gene for inducible TAT suggests the presence in the noninducible hybrid clones of a regulatory protein or some type of repressor of TAT induction. In the hybrid cells derived from the fusion of a differentiated cell (rat hepatoma) with an undifferentiated cell (human fibroblast), the production of such regulatory protein results in the suppression of the differentiated function (TAT induction by corticosteroid hormones).
